Skip to content

To evaluate the efficacy of stage wise treatment protocol over therapeutic purgation in the management of Paralysis

An open labelled randomised clinical trial to evaluate the efficacy of Avasthanusara treatment protocol over virechana in the management of Pakshaghata

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039330
Enrollment
180
Registered
2022-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

None listed

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients fulfilling the diagnostic criteria based on signs and symptoms of paralysis i.e., Loss of bodily functions aphasia Hemiplegia Contractions of bilateral upper and lower limbs

Exclusion criteria

Exclusion criteria: severe hyper tention and diabetes or any other systemic disorders Heamorrhagic hemiplegia subjects who are bedridden patients who are fit for therapeutic purgation and medicated enema procedures

Design outcomes

Primary

MeasureTime frame
Improvement in clinical features of PakshaghataTimepoint: Baseline and After 15 days

Secondary

MeasureTime frame
Improvement in Brunnstrom recovery scale, Modified Ashworth Scale and Barthel IndexTimepoint: Baseline and after 15days

Countries

India

Contacts

Public ContactAsharani Medidar

Parul Institute of Ayurved

manu.r260022@paruluniversity.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026